News

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...
A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...
An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...
Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...
An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...
A study has found that Ozempic may reverse signs of a disease that contributes to 2,000,000 deaths per year. New research has ...
With more than 40% of U.S. adults having been diagnosed with liver disease, Virginia Commonwealth University (VCU) research suggests that there might be a way to treat fatty liver disease.